Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

External Validation of Laboratory-Based Models to Assess Portal Hypertension Severity in Patients with Compensated Chronic Liver Disease.

Digestive diseases and sciences·2026
Same author

Technical and Clinical Outcomes of Embolization of Hypervascular Renal Tumors Using Tantalum-Loaded Obsidio Conformable Embolic (Ta-OCE): a single-center experience.

CVIR oncology·2026
Same author

Comparative Analysis of the LOBO Device and Coils for Proximal Splenic Artery Embolization: A Multi-Institutional Retrospective Study.

Cardiovascular and interventional radiology·2026
Same author

Recent developments and prospects in locoregional therapy of hepatocellular carcinoma.

Abdominal radiology (New York)·2026
Same author

Case Report: Pulsed electric field treatment of metastatic liver disease demonstrating a possible abscopal response.

Frontiers in immunology·2026
Same author

Safety and Effectiveness of the Low-Profile Braided Occluder Vascular Occlusion Device for Embolization of Pulmonary Arteriovenous Malformations: A Single-Center Retrospective Experience.

Journal of vascular and interventional radiology : JVIR·2026

Related Experiment Video

Updated: Jun 30, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

422

Yttrium-90 Radioembolization Dosimetry: Dose Considerations, Optimization, and Tips

Alexander Villalobos1, Johannes L du Pisanie1, Ripal T Gandhi1

  • 1Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Seminars in Interventional Radiology
|March 18, 2024
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K

Related Experiment Videos

Last Updated: Jun 30, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

422
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K